About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05854979

Effects of GLP-1 Agonists on Gastric Volume

This study will enroll patients ages 18 and over who have a diagnosis of diabetes, are undergoing an elective surgery under general anesthesia and 1) are taking a GLP-1 receptor agonist medication, or...

Lead sponsor: Medical University of South Carolina•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Medical University of South Carolina

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age greater than or equal to 18 years old
•Diagnosed with diabetes (listed on medical record, Hgb A1C greater than or equal to 6.5%, fasting blood glucose greater than or equal to 126mg/dL, and/or on medical treatment for diabetes)
•One of the following groups:
•Taking a GLP-1 Medication
•Not taking a GLP-1 Medication
•ASA Physical Classification Status 1-3
•Scheduled for elective surgery under general anesthesia
•Appropriately fasted per ASA Fasting Guidelines 201712

Exclusion Criteria

•BMI greater than 40
•Previous gastric/esophageal surgery
•Abnormal gastric anatomy
•Pregnancy
•Inability or unwillingness of subject to give informed consent
•Non-English Speaking

Related studies

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

NCT06893341 · Diabetes, Hyperglycemia, and more

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

Continuous Glucose Monitoring for Women With Gestational Diabetes

NCT06310356 · Gestational Diabetes

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

RECRUITINGPhase 1

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

NCT07535307 · Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 25, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment210

Start dateAug 2023

Last updatedApr 25, 2024

Condition

Diabetes Gastric Content Aspiration Glucagon-like Peptide 1 GLP-1

Locations shown

Medical University of South Carolina

Charleston, South Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 25, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions